Time-lapse Evaluation of Embryo Development After Stimulation With One of Two Different Gonadotrophins.
NCT01345812 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 291
Last updated 2012-09-14
Summary
The primary purpose of the investigation is to identify differences in embryo development after follicle stimulation with two different gonadotrophins.
Conditions
- Patients for In Vitro Fertilization(IVF)Treatment
Interventions
- DRUG
-
HP-HMG
100 - 300 IU for stimulation of women in ART treatment
- DRUG
-
recombinant FSH
100 -300 IU for stimulation of women in ART treatment
Sponsors & Collaborators
-
The Fertility Clinic Braedstrup Hospital
collaborator UNKNOWN -
Herlev Hospital
collaborator OTHER -
Odense University Hospital
collaborator OTHER -
Trianglen Fertility Clinic
collaborator UNKNOWN -
Aagaard Fertility Clinic
collaborator OTHER -
Ferring Pharmaceuticals
collaborator INDUSTRY -
University of Aarhus
lead OTHER
Principal Investigators
-
Inge Agerholm, Phd · IVF clinic Braedstrup
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 21 Years
- Max Age
- 45 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-04-30
- Primary Completion
- 2012-07-31
- Completion
- 2012-08-31
Countries
- Denmark
Study Locations
More Related Trials
-
Substituted Frozen Embryo Transfer Cycles With GnRH-agonist Supplementation
NCT01943812 ·Status: COMPLETED ·Phase: PHASE4
-
Time-lapse Monitoring of Early Embryo Development After Ovarian Stimulation During Infertility Treatment
NCT01882166 ·Status: TERMINATED ·Phase: NA
-
Effect of GnRH Antagonist vs Agonist Long on IVF Outcome, Peak Estradiol Level,and Duration of Stimulation
NCT01669291 ·Status: COMPLETED ·Phase: NA
-
Oestradiol Pre-treatment in an Ultrashort Flare GnRH Agonist/GnRH Antagonist Protocol in Poor Responders Undergoing IVF
NCT01798836 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Growth Hormone Co-treatment Within a GnRH Antagonist Protocol in Patients With Poor Ovarian Response
NCT03373149 ·Status: UNKNOWN ·Phase: PHASE2
-
Ovarian Response Prediction in In Vitro Fertilization (IVF) Patients
NCT01206803 ·Status: COMPLETED
-
Assessment of the Therapeutic Utility of r-FSH in Association With hMG-HP
NCT01330771 ·Status: COMPLETED
-
Ultrashort GnRH Agonist/Antagonist Versus GnRH Antagonist IVF
NCT02173977 ·Status: UNKNOWN ·Phase: PHASE2
-
Transfer of Fresh Versus Frozen/Thawed Embryos in IVF Cycles Where GnRH Agonist is Utilized for Oocyte Maturation.
NCT00365027 ·Status: WITHDRAWN ·Phase: NA
-
Optimal Stimulation of Hypo-responders Undergoing in Vitro Fertilization (IVF)
NCT07121751 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
The Effect of LH-Priming During Early Follicular Phase in IVF Treatment.
NCT00334425 ·Status: UNKNOWN ·Phase: PHASE4
-
A Phase IV, Prospective, Observational, Open Label, Single Centre Cohort Trial to be Conducted in Norway During One Year to Assess the Cumulative Pregnancy Rate in a New Series of In-vitro Fertilization (IVF) Treatment Cycles Following Three or More Previous IVF Treatment Cycles Without Live Birth
NCT01071148 ·Status: COMPLETED
-
GnRH Agonist for Dual Trigger in IVF and for Luteal Phase Support in FET
NCT04064840 ·Status: RECRUITING ·Phase: PHASE3
-
Gonadotropin Type in Ovarian Stimulation
NCT02437032 ·Status: COMPLETED ·Phase: PHASE4
-
Prospective Assessment of Impact of Personalized Dosing of Low-dose Human Chorionic Gonadotropin (hCG) on in Vitro Fertilization (IVF) Outcomes
NCT04852029 ·Status: TERMINATED ·Phase: NA
-
Growth Hormone (GH) in in Vitro Fertilization (IVF) Poor-responder Patients
NCT01298960 ·Status: TERMINATED ·Phase: PHASE2
-
Controlled Ovarian Stimulation Versus Modified Natural Cycles in Poor Responders
NCT04487925 ·Status: RECRUITING ·Phase: PHASE4
-
Assessment of the Effectiveness and Tolerability of Ovarian Hyperstimulation
NCT01331720 ·Status: COMPLETED
-
Gonadotropin-releasing Hormone (GnRH) Antagonist During 3 Days
NCT01093443 ·Status: COMPLETED ·Phase: PHASE4
-
Follitropin Delta in Long GnRH-agonist Protocol
NCT06995261 ·Status: RECRUITING
-
Earlier Triggering in Rec-FSH/GnRH Antagonist Cycles
NCT01390207 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Low-dose HCG as an Adjunct to Ovarian Stimulation in Subfertile Women Undergoing ART
NCT03423537 ·Status: TERMINATED ·Phase: PHASE3
-
GnRH Agonist as Luteal Support in FET Cycles
NCT02620124 ·Status: COMPLETED ·Phase: PHASE4
-
Dual Trigger With HCG and GnRH Agonist on Thawed Modified Natural Cycle Embryo Transfer
NCT07269392 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Preimplantation Genetic Diagnosis (PGD) With Gonadotropin-releasing Hormone (GnRH) Agonist Versus Antagonist
NCT01888744 ·Status: COMPLETED ·Phase: PHASE4